Fig. 4From: Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastasesDeveloped RSs for the prediction of EGFR mutation (a), exon-19 deletion (b) and exon-21 L858R (c) mutationBack to article page